Author: Richard Hornby

Healthcare providers, payers and regulators are increasingly using sophisticated AI tools to manage and scrutinize reimbursement, marking a new chapter in the ongoing evolution of healthcare reimbursement. The stakes are high, with technology-driven coding errors and claim denials creating significant litigation and financial exposure for payers and providers alike. Against this backdrop, investors should consider how rigorous operational diligence — combined with representations and warranties insurance (RWI) — can help identify and mitigate transaction risk.

But as AI changes the reimbursement environment, what does it mean for healthcare transactions and RWI? Underwriters have not materially changed their diligence expectations, even as insurers become increasingly selective about the healthcare risks they're willing to insure.

In our latest report, we examine what's driving current trends in healthcare reimbursement, the impact of AI, what underwriters are looking for during diligence and how investors and sellers should approach RWI for their next transaction.

Author Information